本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

18.16
-1.5750-7.98%
盤後18.00-0.1600-0.88%19:31 EDT
成交量:306.89萬
成交額:5,680.76萬
市值:28.80億
市盈率:-6.11
高:19.74
開:19.59
低:18.10
收:19.74
52周最高:23.77
52周最低:10.57
股本:1.59億
流通股本:1.44億
量比:0.96
換手率:2.13%
股息:- -
股息率:- -
每股收益(TTM):-2.9700
每股收益(LYR):-2.9700
淨資產收益率:-45.69%
總資產收益率:-27.56%
市淨率:2.84
市盈率(LYR):-6.11

資料載入中...

2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/10

重要事件披露

Form 8-K - Current report
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities